Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Nucor Corporation (NYSE:NUE) fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.Nucor reported quarterly earnings of $3.46 per s
Express News | Carmell Announces Successful Closing of $3.0 Million Private Placement
Express News | Carmell Shares Are Trading Lower After the Company Announced a $3 Million Private Placement of About ~1,333,333 Shares of Its Common Stock at a Price O $2.25 per Common Share
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersCandel Therapeutics (NASDAQ:CADL) shares moved upwards by 64.3% to $2.76 during Thursday's regular session. The market value of their outstanding shares is at $80.9 million. TC BioPharm (Holdin
Carmell Announces $3.0 Million Private Placement
PITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced that it
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
PITTSBURGH, March 27, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Fed Maintains Rate Cut Outlook
The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.9% higher in Thursday's premarket activity after the Federal Reserv
Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket
Carmell (CTCX) said late Wednesday that it has executed an agreement to sell its unit, Axolotl Biologix, which it acquired for $65 million in August of last year. Carmell said the sale is back to the
Carmell Looks to Sell Axolotl Biologix
Express News | Carmell To Sell Its Axolotl Biologix Subsidiary For 3,845,337 Shares Of Carmell Common Stock, 4,243 Shares Of Carmell Preferred Stock And Notes Payable To The Initial Sellers In The Aggregate Amount Of $8M
Carmell Sharpens Aesthetics Focus With Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
PITTSBURGH, March 20, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell", the "Company", "we", "our", or "us"), today announced the execution
Carmell to Host Investor Webinar, "Unveiling the Secretome: On the Eve of Product Launch" Featuring Key Opinion Leaders in the Medical Aesthetics Field
PITTSBURGH, March 18, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell" or the "Company"), today announced it will host an Investor Webinar
12 Health Care Stocks Moving In Friday's Intraday Session
GainersBetter Therapeutics (NASDAQ:BTTX) shares increased by 65.4% to $0.06 during Friday's regular session. The market value of their outstanding shares is at $3.1 million. Carmell (NASDAQ:CTCX) shar
Carmell Shares Up 8.6% Ahead of Commercial Launch For Skincare Product
By Sabela Ojea Shares of Carmell climbed on Monday after the company said it completed the product development of its gold limited edition exclusive skincare product for commercial launch. The share
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024
PITTSBURGH, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Carmell Corporation (NASDAQ:CTCX), a bio-aesthetics company focused on skin and hair health ("Carmell" or the "Company"), today announced that they have completed product
Carmell(CTCX.US) Officer Buys US$1,540 in Common Stocks
$Carmell(CTCX.US)$ Officer Cassaday Bryan J. purchased 440 shares of Common Stocks on Dec 14, 2023 at an average price of $3.5 for a total value of $1,540.Source: Announcement What is statement of cha
Carmell(CTCX.US) Director Buys US$3,456.17 in Common Stocks
$Carmell(CTCX.US)$ Director Frisch Scott M. purchased 904 shares of Common Stocks on Dec 14, 15, 2023 at an average price of $3.8232 for a total value of $3,456.17. This transaction involves other rel
Carmell(CTCX.US) Director Buys US$4,320.29 in Common Stocks
$Carmell(CTCX.US)$ Director Gregory Kathryn purchased 1,130 shares of Common Stocks on Dec 14, 15, 2023 at an average price of $3.8233 for a total value of $4,320.29. This transaction involves other r
Carmell(CTCX.US) Director Buys US$15,330.4 in Common Stocks
$Carmell(CTCX.US)$ Director Upton Richard A purchased 4,400 shares of Common Stocks on Dec 12, 13, 2023 at an average price of $3.484 for a total value of $15,330.4.Source: Announcement What is statem
Carmell(CTCX.US) Director Buys US$7,085.85 in Common Stocks
$Carmell(CTCX.US)$ Director Gregory Kathryn purchased 2,336 shares of Common Stocks on Dec 4, 5, 6, 7, 8, 2023 at an average price of $3.0333 for a total value of $7,085.85. This transaction involves
No Data